GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » Net Cash per Share

PW Medtech Group (HKSE:01358) Net Cash per Share : HK$0.34 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). PW Medtech Group's Net Cash per Share for the quarter that ended in Dec. 2023 was HK$0.34.

The historical rank and industry rank for PW Medtech Group's Net Cash per Share or its related term are showing as below:

HKSE:01358' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.56   Med: 2.41   Max: 30.83
Current: 3.21

During the past 12 years, the highest Price-to-Net-Cash Ratio of PW Medtech Group was 30.83. The lowest was 0.56. And the median was 2.41.

HKSE:01358's Price-to-Net-Cash is ranked better than
72.7% of 326 companies
in the Medical Devices & Instruments industry
Industry Median: 7.3 vs HKSE:01358: 3.21

PW Medtech Group Net Cash per Share Historical Data

The historical data trend for PW Medtech Group's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Net Cash per Share Chart

PW Medtech Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Cash per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.43 1.15 1.79 0.25 0.34

PW Medtech Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Cash per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.79 0.26 0.25 0.26 0.34

Competitive Comparison of PW Medtech Group's Net Cash per Share

For the Medical Instruments & Supplies subindustry, PW Medtech Group's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PW Medtech Group's Price-to-Net-Cash Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PW Medtech Group's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where PW Medtech Group's Price-to-Net-Cash falls into.



PW Medtech Group Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

PW Medtech Group's Net Cash per Share for the fiscal year that ended in Dec. 2023 is calculated as

Net Cash per Share (A: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1744.092-357.736-853.852)/1565.63
=0.34

PW Medtech Group's Net Cash per Share for the quarter that ended in Dec. 2023 is calculated as

Net Cash per Share (Q: Dec. 2023 )
=(Cash, Cash Equivalents, Marketable Securities-Total Liabilities-Minority Interest)/Shares Outstanding (EOP)
=(1744.092-357.736-853.852)/1565.63
=0.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PW Medtech Group  (HKSE:01358) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.


PW Medtech Group Net Cash per Share Related Terms

Thank you for viewing the detailed overview of PW Medtech Group's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


PW Medtech Group (HKSE:01358) Business Description

Traded in Other Exchanges
Address
Building 1, No. 23 Panlong West Road, Pinggu District, Beijing, CHN, 101204
PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the advanced infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business.
Executives
Right Faith Holdings Limited 2101 Beneficial owner
Chan Marc 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc 2101 Beneficial owner
Cross Mark Limited 2101 Beneficial owner
Liu Yufeng 2201 Interest of corporation controlled by you
Zhang Zaixian 2202 Interest of your spouse

PW Medtech Group (HKSE:01358) Headlines

No Headlines